Dissection

3

Review clinical trials related to Dissection. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Long-term Characterization of GORE® TAG® Conformable Thoracic Stent Graft With ACTIVE CONTROL System Performance

An observational, prospective multi-regional post-market registry collecting mid- and long-term data to assess outcomes through ten years of follow-up for subjects treated with GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System as a part of routine clinical practice. This post-market registry for the GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System (CTAG w/AC) is intended to demonstrate that thoracic endovascular aortic repair (TEVAR) for lesions of the descending thoracic aorta continues to be a suitable treatment option for appropriately selected patients.

Participants needed: 1,500
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: W.L.Gore & AssociatesUpdated: Jun 23, 2026Locations: 36Duration: 10 Years
Eligibility criteria

Patient or legally authorized representative (LAR) provides written authorizatio... [+3]

Patient who is, at the time of consent, unlikely to be available for standard of... [+3]

Status: Recruiting

PANTHER Study of Terumo Aortic Knitted and Woven Grafts, and Cardiovascular Patches

The purpose of this registry is to collect safety and performance data on all commercially available Terumo Aortic knitted and woven grafts, and cardiovascular patches in standard clinical practice. Data will be collected both retrospectively and prospectively.

Participants needed: 2,000
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Vascutek Ltd.Updated: Jun 3, 2025Locations: 31Duration: 10 Years
Eligibility criteria

Patient meets the minimum age as per local regulations at time of consent [+7]

Patient is unable or unwilling to comply with the SOC procedures or follow-up re... [+2]

Status: Recruiting

A Trail of Sperstent® Used for Residual Lesions of Femoropopliteal Arteries

This is a prospective, multi-center, randomized trial designed to investigate the efficacy and safety of Sperstent® peripheral spot stent system versus Everflex® self-expanding peripheral stent system in the endovascular treatment of post-balloon angioplasty (post-PTA) residual lesions including stenoses and/or dissections in femoral and proximal popliteal arteries.

Participants needed: 240
Trial details
Age: 18-85Biological sex: AllType: InterventionalSponsor: FrontAce Scientific Co., LtdUpdated: Aug 6, 2024Locations: 12
Eligibility criteria

Age 18-85 years old, male or female; [+9]

Target vessel had undergone open surgery such as bypass surgery or the target le... [+19]